James F. Cummings

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

Samuel McConkey, William H. H. Reece, Vasee Moorthy et al. · Nature Medicine · 2003 · 557 citations · Full text

Vaccination, Vaccine Development, Immunology +8

Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

Kent E. Kester, James F. Cummings, Opokua Ofori‐Anyinam et al. · The Journal of Infectious Diseases · 2009 · 533 citations · Full text

Sarcocystis neurona n. sp. (Protozoa: Apicomplexa), the Etiologic Agent of Equine Protozoal Myeloencephalitis

J. P. Dubey, S. W. Davis, C. A. Speer et al. · Journal of Parasitology · 1991 · 253 citations · Full text

Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

Michele Spring, James F. Cummings, Christian F. Ockenhouse et al. · PLoS ONE · 2009 · 207 citations · Full text

Common and Divergent Immune Response Signaling Pathways Discovered in Peripheral Blood Mononuclear Cell Gene Expression Patterns in Presymptomatic and Clinically Apparent Malaria

Christian F. Ockenhouse, Wan‐Chung Hu, Kent E. Kester et al. · Infection and Immunity · 2006 · 145 citations · Full text

Inflammation, Cytokine, Autoimmune Disease +15